Impact of Dexmedetomidine Infusion on Opioid and Benzodiazepine Doses in Ventilated Pediatric Patients in the Cardiac Intensive Care Unit
- 7 August 2023
- journal article
- research article
- Published by Springer Nature in Pediatric Drugs
- Vol. 25 (6) , 709-718
Abstract
Introduction Dexmedetomidine (DEX) is frequently used as an adjunct agent for prolonged sedation in the intensive care unit (ICU), though its effect on concomitant opioids or benzodiazepines infusions is unclear. We explored the impact of DEX on concomitant analgosedation in a cohort of ventilated pediatric patients in a cardiac ICU, with stratification of patients according to duration of ventilation (< 5 versus ≥ 5 days) following DEX initiation. Methods We conducted a retrospective analysis on ventilated patients receiving a DEX infusion ≥ 24 h and at least one other sedative/analgesic infusion (January 2011–June 2021). We evaluated trends of daily doses of opioids and benzodiazepines from 24 h before to 72 h following DEX initiation, stratifying patients based on ventilation duration after DEX initiation (< 5 versus ≥ 5 days). Results After excluding 1146 patients receiving DEX only, 1073 patients were included [median age 234 days (interquartile range 90, 879)]. DEX was associated with an opioid infusion in 99% of patients and a benzodiazepine infusion in 62%. Among patients ventilated for < 5 days (N = 761), opioids increased in the first 24 h following DEX initiation [+ 1.12 mg/kg/day (95% CI 0.96, 1.23), P < 0.001], then decreased [− 0.90 mg/kg/day (95% CI − 0.89, − 0.71), P < 0.001]; benzodiazepines slowly decreased [− 0.20 mg/kg/day (95% CI − 0.21, − 0.19), P < 0.001]. Among patients ventilated for ≥ 5 days (N = 312), opioid administration doubled [+ 2.09 mg/kg/day (95% CI 1.82, 2.36), P < 0.001] in the first 24 h, then diminished minimally [− 0.18 mg/kg/day (95% CI − 0.32, − 0.04), P = 0.015] without returning to baseline; benzodiazepine administration decreased minimally [− 0.03 mg/kg/day (95% CI − 0.05, − 0.01), P = 0.010]. Similar trends were confirmed when adjusting for age, gender, surgical complexity, recent major invasive procedures, duration of mechanical ventilation before DEX initiation, extubation within 72 h following DEX initiation, mean hourly DEX dose, and use of neuromuscular blocking infusion. Conclusion While in patients ventilated < 5 days opioids initially increased and then quickly decreased in the 72 h following DEX initiation, among patients ventilated ≥ 5 days opioids doubled, then decreased only minimally; benzodiazepines decreased minimally in both groups, although more slowly in the long-ventilation cohort. These findings may inform decision-making on timing of DEX initiation in ventilated patients already being treated with opioid or benzodiazepine infusions.Keywords
This publication has 23 references indexed in Scilit:
- Dexmedetomidine: review, update, and future considerations of paediatric perioperative and periprocedural applications and limitationsBritish Journal of Anaesthesia, 2015
- Protocolized Sedation vs Usual Care in Pediatric Patients Mechanically Ventilated for Acute Respiratory FailureJAMA, 2015
- Defining sedation-related adverse events in the pediatric intensive care unitHeart & Lung, 2013
- Safety and efficacy of prolonged dexmedetomidine use in critically ill children with heart disease*Pediatric Critical Care Medicine, 2012
- Hemodynamic Effects of Dexmedetomidine in Critically Ill Neonates and Infants With Heart DiseasePediatric Cardiology, 2012
- Dexmedetomidine in ChildrenAnesthesia & Analgesia, 2011
- Dexmedetomidine sedation in children after cardiac surgery*Pediatric Critical Care Medicine, 2010
- Dexmedetomidine use in a pediatric cardiac intensive care unit: Can we use it in infants after cardiac surgery?Pediatric Critical Care Medicine, 2009
- Use of Dexmedetomidine in the Pediatric Intensive Care UnitPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2008
- Sedation Using Dexmedetomidine in Pediatric Burn PatientsJournal of Burn Care & Research, 2006